Biohaven Pharmaceutical Holding Company Ltd. Gains 33.31%
Wed, Sep 27, 2023 at 07:34 PM
Biohaven Pharmaceutical Holding Company Ltd. (BHVN:NYSE) rocketted at $23.53, a gain of 33.3%. On Wed, Sep 27, 2023, BHVN:NYSE hit a New 2-Week High of $23.53. The stock got featured on our News Catalysts scanner on Thu, Sep 14, 2023 at 07:59 AM in the 'BIOTECH' category. From Wed, Sep 13, 2023, the stock recorded 50.00% Up Days and 45.45% Green Days
About Biohaven Pharmaceutical Holding Company Ltd. (BHVN:NYSE)
Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.
Top 10 Gainers:
- ShiftPixy, Inc. (PIXY:NASDAQ), 141.38%
- Digital Transformation Opportunities Corp. (DTOC:NASDAQ), 89.56%
- MSP Recovery Inc. (LIFW:NASDAQ), 46.35%
- Biohaven Pharmaceutical Holding Company Ltd. (BHVN:NYSE), 33.31%
- SciSparc Ltd. (SPRC:NASDAQ), 32.78%
- New York City REIT Inc. Class A (NYC:NYSE), 28.62%
- MillerKnoll Inc. (MLKN:NASDAQ), 27.99%
- IronNet Inc. (IRNT:NYSE), 24%
- Mobile Global Esports Inc. (MGAM:NASDAQ), 22.86%
- Theratechnologies Inc. (THTX:NASDAQ), 22.86%